Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Clinical manifestations, laboratory markers, and renal ultrasonographic examinations in 1-month to 12-year-old Iranian children with pyelonephritis: a six-year cross-sectional retrospective study

BMC Infectious Diseases volume 21, Article number: 189 (2021) Cite this article

Abstract

Background

Upper urinary tract infection (UTI) or pyelonephritis may increase the pathogenesis rate and risk of severe complications in children due to kidney atrophy.

Objective

A set of clinical symptoms, laboratory markers, and ultrasound findings were assessed to achieve the early diagnosis and prognosis of pyelonephritis in hospitalized pediatrics.

Methods

A cross-sectional study with 104 Iranian children (95 girls and 9 boys) aged 1 month to 12 years with acute pyelonephritis during 2012–2018 was conducted. The ultrasound examination of kidneys and urinary tract during hospitalization, the incidence of clinical symptoms, and laboratory markers in blood and urine were monitored to identify the best predictive factors of early diagnosis of this bacterial infection.

Results

Three-fourth of the patients had one of the four clinical symptoms of abdominal pain, constipation, dysuria, and vomiting, while others were asymptomatic. A much frequency of pyuria (88.46%), Escherichia coli in urine (92.31%), leukocytosis (81.73%), and high ESR (> 10 mm/h, 92.30%) and CRP (> 10 mg/L, 82.82%) was observed. The kidney and urinary tract ultrasonography only in 32.7% of children revealed findings in favor of pyelonephritis (cystitis, ureteral stones, and hydronephrosis).

Conclusion

There was a high frequency of clinical signs and laboratory markers associated with pyelonephritis. Ultrasound alone was not an efficient tool to track febrile UTI as most patients presented normal sonography.

Peer Review reports

Background

Febrile urinary tract infections (UTIs) or acute pyelonephritis (AP) is one of the most common bacterial infections of the renal pelvis and kidney among children and young adult women [1]. It has been reported that the annual cost of treating this disease in France and the US was about €58 million and $2.47 billion, respectively [2, 3]. In childhood, this disease usually occurs in boy infants due to congenital anomalies of kidneys and urinary tract, while AP is observed in girls at older ages [4,5,6]. Escherichia coli is the main responsible pathogen for AP. This pathogen often causes severe inflammation and short-term (e.g., fever, dysuria, and flank pain) and long-term (e.g., irreversible renal scarring) morbidities [7, 8]. The renal scarring significantly develops the risk of hypertension, proteinuria, vesicoureteral reflux (VUR), chronic kidney disease, and end-stage renal disease [9, 10]. Since renal scarring is observed in 37% of AP children after two years from the infection onset, the rapid diagnosis and implementation of effective therapeutic measures are necessary to manage this disease among children [4, 11,12,13].

Although some complications such as dysuria, urgency, hesitancy, small-volume voids, or lower abdominal pain were recognized in children with UTI at older ages, infants involved with this disease usually appear non-specific symptoms like fever, failure to thrive, jaundice, irritability, and vomiting [14, 15]. On the other hand, the definitive analysis among infants with UTI involves bladder catheterization due to the nonspecific signs and symptoms of UTI in pediatric populations. Besides, clinical strategies driven by antibiotic prophylaxis or imaging tools have been recently implemented for hospitalized children with UTIs. Accordingly, several imaging techniques such as ultrasound, micturition cystourethrogram, and Tc-99 m dimercaptosuccinic acid along with a broad spectrum of intravenous prophylactic antibiotics were recommended to monitor and treat febrile UTIs (e.g., VUR and renal scarring) in children [8, 16].

Although there are many studies on the association between demographic and laboratory factors and the AP severity in children, little evidence on the combination of findings obtained from clinical manifestations, markers, and renal sonography among Iranian children within a wide age range has been published. For the first time, the efficiency of ultrasonographic examinations and antibiotics to diagnose and treat AP among Iranian infants and children was first conducted based on a high number of clinical manifestations, laboratory markers, and complications. As a result, the objective of this six-year cross-sectional study was to scrutinize the febrile UTI in 1-month to 12-year-old Iranian children based on clinical outcomes and signs, as well as renal ultrasound findings to adopt clinical practices and diagnostic tools/markers for a notable contribution to the early disease prognosis, monitoring, and treatment in the future.

Methods

Study design and participants

A cross-sectional study was designed to evaluate laboratory signs, clinical symptoms, and ultrasonography examinations obtained from 104 children with AP who were hospitalized in Bahrami Hospital (Tehran, Iran) from 2012 to 2018. The sampling method was the census so that all the admitted children with AP were assessed to find early prognosis and diagnosis markers. The number of collected samples was adequate since several previous studies with the same count of participants were successfully implemented [17,18,19]. The verbal and written informed consent using phone contacts and face-to-face interviews was obtained from all the parents after mentioning the study objective and used methodology. This research was performed following the Declaration of Helsinki and approved by the Human Ethics Committee of the Tehran University of Medical Sciences (TUMS).

Inclusion and exclusion criteria

In this study, only pediatric patients with AP aged from 1 month to 12 years old were included. The AP was diagnosed after the specialist’s approval according to an axillary temperature of higher than 38.5 °C, bad general conditions, and positive urine culture (PUC). For the definition of PUCs, the significant microbial growth was considered based on standard microbiological criteria. Accordingly, the colony count in the midstream urine sample was more than or equal to 105 CFU/mL of a single pathogen, or ≥ 104 CFU/mL microorganisms counted with the reference catheter method, and/or ≥ 103 Gram-positive bacteria in urine culture taken by the suprapubic method [20]. Besides, children with negative urine culture (NUC) and those who had an NUC after the antibiotic administration were excluded from the study.

Data collection

The medical information of all patients with AP was completed from archived electronic files from March 2012 to March 2018. After ensuring the pyelonephritis diagnosis accuracy, the necessary information was extracted by referring to the medical history, disease course, and summary of patients’ files. Patients were included in the pre-prepared questionnaire form if they met the inclusion criteria. This questionnaire consisted of the patient’ name, gender, age, height, weight, body mass index (BMI, kg/m2), hospitalization stay, fever degree, fever duration before and after the antimicrobial therapy, drug treatment (intravenous antibiotic type), and the history of having constipation, dysuria, vomiting, and abdominal pain during hospitalization. Children were classified into four classes of underweight, normal, overweight, and obese based on the BMI reported by the Centers for Disease Control and Prevention (CDC) growth charts [16]. Also, the results of laboratory markers such as urine culture (negative/positive), microorganism type in PUC, urine analyses (e.g., pyuria (white blood cells (WBCs) per mm3), hematuria (red blood cells (RBCs) per high-power field (HPF)), and positive nitrite), and levels of hematological factors (e.g., hemoglobin (Hb, ng/mL), erythrocyte sedimentation rate (ESR, mm/h), and C-reactive protein (CRP, mg/L), WBCs (count per mm3), blood urea nitrogen (BUN, mg/dL), serum creatinine (SCr, mg/dL), potassium (K, mEq/L), and sodium (Na, mEq/L) were recorded. Then, findings obtained from ultrasound examinations of kidneys and urinary tract in terms of renal anomalies, cystitis, ureteral stones, and hydronephrosis during hospitalization stay were collected. Ultrasound imaging was conducted by two ultrasonographers. The first observer was blinded to the results of the ultrasound examination of the second observer. The inter-observer agreement between observers of differing levels of expertise was assessed according to the kappa statistic. Lastly, the kidney function level was assessed according to the estimated glomerular filtration rate (eGFR, mL/min/1.73 m2) using the following equation [21]:

$$ eGFR=\frac{0.413\times Height(cm)}{SCr\ \left( mg/ dL\right)} $$
(1)

Statistical analysis

The one-sample Kolmogorov-Smirnov test was used to evaluate the normality of variables distribution. Data were examined at a significance level of p < 0.05. The descriptive data were expressed as frequency, percentage, and mean ± standard deviation. The statistical differences were determined using the independent t-test for continuous variables and Pearson’s Chi-square (χ2) test for categorical variables. The one-sample Kolmogorov-Smirnov test was used to evaluate the data distribution normality. The non-parametric, Mann–Whitney test was used for the data analysis with an abnormal distribution. Pearson’s coefficient was considered to find significant correlations between tested variables.

Results

The average age of 104 patients with AP was 47.08 years. Nighty-five (91.34%) of the studied patients were girls. The minimum, mean, and maximum values of patients’ height and weight were 52 cm and 3.3 kg, 94.26 cm and 15.77 kg, and 147 cm and 69.9 kg, respectively. The highest and lowest BMI were respectively calculated to be 10 and 28 kg/m2, while the mean BMI of the total population with AP was 16.29 kg/m2 (Table 1). Table 2 exhibits the frequency of BMI classes as a function of gender differences and age groups (< 1, 1–5, and >  5 years old). Most children (girls, 62.1%; boys, 44.4%) had a normal range of BMI. Also, almost equal numbers of children were in different age ranges (31.73–34.61%, Table 2). Based on the age group classification, most overweight children had an age of less than one-year-old (n = 23) and over 5 years old (n = 23) (Table 2).

Table 1 The demographic and laboratory parameters of children with AP
Full size table
Table 2 The frequency of BMI classes of children with AP within different gender and age groupsa
Full size table

The minimum and maximum time of hospitalization stay were 2 days (n = 9) and 16 days (n = 1), respectively (Table 1). In general, 75% of the patients with AP were symptomatic. A high number of girls (78.9%) were symptomatic, while most boys (66.7%) were asymptomatic (Fig. 1a). This finding indicates that UTIs may occur in boys with fewer clinical symptoms. Thus, this population group needs further laboratory investigations. Also, the percentage of asymptomatic children in three age groups of < 1, 1–5, and >  5 years old was 47.2, 12.1, and 14.3%, respectively (Fig. 1b). Hence, asymptomatic was more common at younger ages. The symptomatology rate was increased with increasing age, although there was no significant difference in this index between age groups of 1–5 and > 5 years old. As 20.19% (n = 21) of the patients with AP complained of constipation, this symptom can be considered as a risk factor for UTIs. Fever as the main inclusion criterion for all patients averagely was at 39.4 °C, at admission time, while the minimum and maximum temperature degrees were 38.5 and 41.0 °C, respectively. The shortest and longest fever durations before the treatment were 1 day (n = 10) and 7 days (n = 6), respectively (Table 1). Although the child’s fever duration before starting the antimicrobial therapy does not play a role in confirming or rejecting a UTI, a delay in beginning the treatment can significantly have consequences like renal scarring. Three cases did not show fever after the treatment, while fever in the two other cases continued for up to 5 days after the treatment, showing a necessity to change the used antibiotic type. As dysuria was observed among 30 patients with AP (28.84%), the absence of dysuria does not rule out a UTI. Abdominal pain and vomiting were detected in 33.65% (n = 35) and 40.38% (n = 42) of the subjects, respectively (Table 3). Based on Pearson’s Chi-square analysis, there were significant associations between patients’ age and symptoms of dysuria (p = 0.003) and abdominal pain (p = 0.0001).

Fig. 1
figure 1

The frequency ofsymptomatology of the children population with AP based on gender (a) and age range (b), and the percentage of positive urine markers in age groups (c)

Full size image
Table 3 A summary of urine markers, clinical complications, and ultrasound findings of children with AP
Full size table

Pyuria and hematuria usually respectively are the presence of ≥10 WBCs/mm3 and ≥ 5RBCs/HPF in a urine specimen. Pyuria, hematuria, and positive nitrite were respectively diagnosed in 88.46% (n = 92), 38.46% (n = 40) and 45.19% (n = 47) of urine tests of patients with AP (Table 3). As a result, not only pyuria can be one of the most important symptoms of UTI, but also not having hematuria and urine nitrite do not rule out this disease. Figure 1c shows that these abnormal urinary changes were increased by increasing the age from < 1 to > 5 years old. In addition, there was a negative correlation between and eGFR and patients’ age (r = 0.754, p = 0.001). Results proved that this increase in the urine nitrite (50.0%) was more evident than hematuria (36.36%) and pyuria (10.12%) (Fig. 1c). E. coli was the most frequent pathogen in urine samples so that this bacterium was present in samples of 96 patients (92.31%). Other bacteria such as Gram-negative Bacillus (2 cases), Group-B Streptococcus (2 cases), Klebsiella pneumoniae (1 case), Acinetobacter (1 case), Enterococcus (1 case), and Staphylococcus aureus (1 case) were observed in urine samples taken from patients less than one-year-old (Table 4). Ceftizoxime was the most common intravenous antibiotic to treat patients with AP (n = 78, 75.0%). Other used antibiotics were ceftriaxone (n = 12, 11.53%), amikacin (n = 7, 6.73%), cefotaxime (n = 2, 1.92%), cefepime (n = 2, 1.92%), vancomycin (n = 1, 0.96%), meropenem (n = 1, 0.96%), and gentamicin (n = 1, 0.96%) (Table 4). Patients receiving two antibiotics of vancomycin and meropenem had abnormal ultrasound results. But, the administration of other antibiotics led to more normal sonographic findings. Pearson’s Chi-square analysis also showed that there were significant correlations between gender and antibiotic type (p = 0.0001) and hospitalization stay (p = 0.001). Thus, a proper choice of used antibiotics can significantly reduce fever degree and duration, and subsequently, the hospitalization stay of children with AP.

Table 4 The type of identified pathogens and used antibiotics to treat 104 children with AP
Full size table

Overall, ESR and CRP values had recorded for 91 and 99 patients with AP, respectively. The minimum, mean, and maximum levels of ESR and CRP were 3 mm/h and 1 mg/L, 46.5 mm/h and 58.7 mg/L, and 108 mm/h and 118 mg/L, respectively (Table 1). The elevated ESR (> 10 mm/h) and CRP (> 10 mg/L) levels [22] were observed in 84 (92.30%) and 82 (82.82%) patients, respectively. Therefore, only 7 and 17 patients respectively had an ESR and CRP within a normal range. Accordingly, high amounts of these hematological factors may be effective in the diagnosis of patients with AP. The minimum, mean, and maximum amounts of BUN and SCr were 5 and 0.05 mg/dL, 11.31 and 0.57 mg/dL, and 62 and 2.4 mg/dL, respectively. Also, the minimum and maximum eGFR amounts respectively were 17.2 and 134 mL/min/1.73 m2, while the average value of this index was calculated to be 68.94 mL/min/1.73 m2 (Table 1). Also, the lowest, average, and highest values of WBCs and Hb were 3.6/mm3and 7.6 ng/mL, 14.90/mm3and 11.02 ng/mL, and 34/mm3and 14.7 ng/mL, respectively (Table 1). The frequency of leukocytosis and anemia in the studied population was 81.73% (n = 85) and 36.53% (n = 38), respectively. The mean Na and K amounts in blood samples were 140.7 and 4.36 mEq/L, respectively. The lowest and highest values of Na and K were 131 and 3.5 mEq/L, and 152 and 5.8 mEq/L, respectively (Table 1).

In general, 67.3% of the patients had normal sonographic examinations. A good inter-observer agreement was found for ultrasound imaging in the study years (kappa value: 0.751–0.837). Sonographic findings showed the presence of hydronephrosis, cystitis, and renal anomalies in 22 (21.15%), 9 (8.65%), and 2 (1.92%) patients with AP, respectively (Table 3). However, none of the patients showed ureteral stones on their ultrasound images. Consequently, hydronephrosis was the most common abnormality detected in the ultrasonography of kidneys and urinary tract. Since sonography results of 70 patients (67.3%) were not in favor of pyelonephritis, ultrasound alone cannot be a valid diagnostic technique for this disease.

Discussion

A particular interest in the field of pediatric studies is early diagnosis and discrimination of AP from other UTIs such as cystitis because of long-term morbidities and serious complications. Girls than boys are more susceptible to get involved in AP due to their shorter urethras [23]. However, boy populations with UTIs typically have underlying anatomical or functional abnormalities of the genitourinary tract with a higher primary scarring rate [23]. E. coli is the most common AP-causing pathogen in children. It was previously shown that this Gram-negative rod bacterium was present in 69% of the English patients with AP, while K. pneumoniae, E. faecalis, Proteus mirabilis, and Pseudomonas aeruginosa caused 3–6% of AP in other patients [24]. Mahmoudi et al. [25] and Sarvari et al. [26] earlier reported the frequent presence of E. coli in urine samples collected from Iranian pediatric populations with AP. Since E. coli is the main pathogen responsible for AP, the antimicrobial sensitivity profile of this member of the family Enterobacteriaceae should be considered as a principle in determining the empirical therapeutic protocols [17]. The number of symptomatic patients with AP in this study was higher compared to that of in the study of Mahmoudi et al. (12.8%) [25]. Although Muhammad et al. [27] explained that constipation is a frequent and overlooked problem in children with UTI symptoms, most patients in this study (79.81%) did not show constipation complications. Pelvic floor dynamics are significantly worsened with this complication. The existence of large stool masses accompanied by volitional holding delays/prevents the complete bladder emptying because of pain with defecation. This mechanism leads to the high accumulation of post-void residuals facilitating bacterial colonization (such as E. coli) in the bladder [28, 29]. The guideline available in the American Academy of Pediatrics recommends pyuria as a clinical factor to diagnose UTIs [30]. Pyuria was the common factor in most children with AP in the present study (88.46%). The pyuria percentage in this research was in agreement with the findings of Nickavar and Sadeghi-Bojd [31] and Shaikh et al. [32] who respectively reported 81 and 87% pyuria among Iranian and American children with AP. Also, Renata et al. [33] pointed out that the frequency of pyuria among the studied Israeli infants and children was 93.5%. They also showed that patients with pyuria significantly had higher concentrations of urinary interleukin-6 (UIL-6) and interleukin-8 (UIL-8) [33]. As a laboratory factor in diagnosing AP in children, we found that the presence of nitrite in urine samples was more pronounced than hematuria. The positive nitrite reaction is a specific test so that it only detects Gram-negative coliforms, whereas atypical pathogens (such as Pseudomonas and Gram-positive organisms) cannot be identified [34]. Moreover, high urine-specific gravity can remarkably reduce the sensitivity of this test [35]. However, as the presence of atypical pathogens in urine samples was insignificant, this factor in our study was relatively appropriate to detect children with AP. The prevalence rate of leukocytosis as a common feature of inflammatory reaction in the current study (81.73%) was much more than that of (56%) in Ayazi et al. [22]. Lee et al. [36] also mentioned leukocytosis as an important risk factor for renal scar formation in Korean infants with the first episode of AP. Shah and Upadhyay [37] earlier reported a significant increase in leukocytosis among children with AP. CRP is synthesized by the liver in response to inflammatory cytokines, particularly UIL-6. ESR shows the complete acute phase process mainly as a response to the production of fibrinogen [38]. The levels of CRP and ESR also were much more than the measured amounts in studies conducted by Ayazi et al. [22] and Naseri [39]. This fact showed that the high amounts of these hematological factors were risk factors to develop renal scars in the long-term follow-up. Jung and Lee [40] proved that UTI infants with a higher CRP significantly had higher cortical defect on an acute dimercaptosuccinic acid (DMSA) scan. Rodríguez et al. [41] revealed that CRP can be considered a valid test to diagnose febrile UTI with high sensitivity (83.3%) compared to UIL-6 (77.8%). In contrast, Lin et al. [42] reported that ESR and CRP had a relatively low sensitivity to diagnose UTI in febrile infants.

Ultrasound not only is a non-invasive, easily repeatable, safe, and relatively cheap technique to diagnose infectious diseases but also it does not require any sedation and is easy to examine bedside [43]. Other benefits of ultrasound are the lack of ionizing radiation hazards, general availability, and patient acceptability [44]. Sonography examinations showed that only 34 patients were in favor of AP with a more appearance of hydronephrosis. The size of kidneys during AP may be enlarged so that they have hypoechoic parenchyma with a loss of the normal corticomedullary junction [45]. Our ultrasonographic findings demonstrated that this imaging tool did not have sufficient adequacy to diagnose AP as it may miss parenchymal and perinephric abnormalities [46]. Thus, other diagnostic methods in combination with ultrasound should be used to monitor AP in pediatric patients due to the disadvantages such as the accepted low sensitivity, high operator dependence, and required expertise for the data interpretation [47, 48]. It has been recently reported that the combined use of ultrasound with DMSA scintigraphy [49], voiding cystourethrogram [50], and technetium-99 m DMSA (99mTc-DMSA) scintigraphy [51, 52] can highly improve the diagnostic accuracy of AP among pediatric patients.

Limitations

Although there was a normal range of patients in this study similar to other studies, more count of subjects in this six-year cross-sectional study could present the data with better reliability and generalizability. The evaluation of AP in larger population sizes from several hospitals in different geographical areas is recommended because this work was performed in a single academic hospital, limiting its generalizability to other centers and settings. Another limitation is no record of the used dose of each antibiotic to decide about the therapeutic potential and its effects on the fever duration and hospitalization stay. Hence, the present study cannot be a criterion to choose appropriate antibiotic treatments for AP in children populations. The other limitation was the failure to record inflammatory markers in medical files. The assessment of molecular mechanisms regulating the inflammatory profile could contribute to more comprehension of the overall pathogenesis and clinical outcomes of pediatric UTIs to define the best type and dose of antibiotics with the lowest acquired resistance.

Conclusions

The present study showed that the AP in most Iranian children was symptomatic and mainly caused by E. coli. This bacterial infection was highly associated with some urine (pyuria and urine nitrite) and hematological (high levels of CRP and ESR, and leukocytosis) factors. Furthermore, the most common antibiotics used to treat AP were ceftriaxone and amikacin. Even though the management of AP is a challenging and controversial process in pediatric populations, the detection, treatment, and follow-up of children with AP should be conducted according to the efficient medical guidelines by pediatricians and renal specialists. Findings obtained from accurate markers for the early prognosis, diagnosis, and treatment of AP based on urine and hematological analyses, antibiotic therapies, and imaging tools would be helpful to overcome this common health problem in childhood. As ultrasonographic findings were not efficient to differentiate pediatrics with and without AP, the use of other imaging diagnostic tools alone or in combination with ultrasound can provide better diagnostic performance.

Availability of data and materials

All the data of this case series are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Abbreviations

AP:

Acute pyelonephritis

BMI:

Body mass index

BUN:

Blood urea nitrogen

CRP:

C-reactive protein

99mTc-DMSA:

Technetium-99 m dimercaptosuccinic acid

ESR:

Erythrocyte sedimentation rate

Hb:

Hemoglobin

HPF:

High-power field

PUC/NUC:

Positive/negative urine culture

RBCs:

Red blood cells

SCr:

Serum creatinine

UTI:

Urinary tract infection

VUR:

Vesicoureteral reflux

UIL:

Urinary interleukin

WBCs:

White blood cells

References

  1. Morello W, La Scola C, Alberici I, Montini G. Acute pyelonephritis in children. Pediatr Nephrol. 2016;31:1253–65. https://doi.org/10.1007/s00467-015-3168-5.

    Article  PubMed  Google Scholar 

  2. Francois M, Hanslik T, Dervaux B, Le Strat Y, Souty C, Vaux S, et al. The economic burden of urinary tract infections in women visiting general practices in France: a cross-sectional survey. BMC Health Serv Res. 2016;16:365. https://doi.org/10.1186/s12913-016-1620-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sanyal C, Husereau DR, Beahm NP, Smyth D, Tsuyuki RT. Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists. BMC Health Serv Res. 2019;19(1):499. https://doi.org/10.1186/s12913-019-4303-y.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Jung HJ, Choi MH, Pai KS, Kim HG. Diagnostic performance of contrast-enhanced ultrasound for acute pyelonephritis in children. Sci Rep. 2020;10(1):10715. https://doi.org/10.1038/s41598-020-67713-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Mojtahedi SY, Rahbarimanesh A, Khedmat L, Izadi A. The prevalence of risk factors for the development of bacteraemia in children. Open Access Maced J Med Sci. 2018;6(11):2023–9. https://doi.org/10.3889/oamjms.2018.418.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rahbarimanesh A, Mojtahedi SY, Sadeghi P, Ghodsi M, Kianfar S, Khedmat L, Siyahkali SJ, Yazdi MK, Izadi A. Antimicrobial stewardship program (ASP): an effective implementing technique for the therapy efficiency of meropenem and vancomycin antibiotics in Iranian pediatric patients. Ann Clin Microbiol Antimicrob. 2019;18(1):6. https://doi.org/10.1186/s12941-019-0305-1.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Karavanaki KA, Soldatou A, Koufadaki AM, Tsentidis C, Haliotis FA, Stefanidis CJ. Delayed treatment of the first febrile urinary tract infection in early childhood increased the risk of renal scarring. Acta Paediatr. 2017;106(1):149–54. https://doi.org/10.1111/apa.13636.

    Article  CAS  PubMed  Google Scholar 

  8. Simões AC, Oliveira EA, Mak RH. Urinary tract infection in pediatrics: an overview. J Pediatr. 2020;96:65–79. https://doi.org/10.1016/j.jpedp.2019.10.006.

    Article  Google Scholar 

  9. Izadi A, Khedmat L, Tavakolizadeh R, Mojtahedi SY. The intake assessment of diverse dietary patterns on childhood hypertension: alleviating the blood pressure and lipidemic factors with low-sodium seafood rich in omega-3 fatty acids. Lipid Health Dis. 2020;19:65. https://doi.org/10.1186/s12944-020-01245-3.

    Article  CAS  Google Scholar 

  10. Sun Y. Risk factors for renal scarring in children. J Clin Pediatr. 2017;35(9):713–5. https://doi.org/10.3969/j.issn.1000-3606.2017.09.019.

    Article  Google Scholar 

  11. Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008;27(4):302–8. https://doi.org/10.1097/INF.0b013e31815e4122.

    Article  PubMed  Google Scholar 

  12. Mofid V, Izadi A, Mojtahedi SY, Khedmat L. Therapeutic and nutritional effects of synbiotic yogurts in children and adults: a clinical review. Probiotics Antimicrob Proteins. 2020;12:851–9. https://doi.org/10.1007/s12602-019-09594-x.

    Article  CAS  PubMed  Google Scholar 

  13. Izadi A, Khedmat L, Mojtahedi SY. Nutritional and therapeutic perspectives of camel milk and its protein hydrolysates: a review on versatile biofunctional properties. J Funct Food. 2019;60:103441. https://doi.org/10.1016/j.jff.2019.103441.

    Article  CAS  Google Scholar 

  14. Struthers S, Scanlon J, Parker K, Goddard J, Hallett R. Parental reporting of smelly urine and urinary tract infection. Arch Dis Child. 2003;88:250–2. https://doi.org/10.1136/adc.88.3.250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Alper BS, Curry SH. Urinary tract infection in children. Am Fam Physician. 2005;72(12):2483–8 PMID: 16370404.

    PubMed  Google Scholar 

  16. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120:S164–92. https://doi.org/10.1542/peds.2007-2329C.

    Article  PubMed  Google Scholar 

  17. Flor-de-Lima F, Martins T, Teixeira A, Pinto H, Botelho-Moniz E, Caldas-Afonso A. Etiological agents and antimicrobial susceptibility in hospitalized children with acute pyelonephritis. Acta Med Port. 2015;28(1):15–20. https://doi.org/10.20344/amp.5033.

    Article  PubMed  Google Scholar 

  18. Ayazi P, Mahyar A, Noroozian E, Esmaeilzadehha N. Comparison of renal ultrasonography and dimercaptosuccinic acid renal scintigraphy in febrile urinary tract infection. Infez Med. 2015;23(4):323–9.

    PubMed  Google Scholar 

  19. Juliano TM, Stephany HA, Clayton DB, Thomas JC, Pope JC, Adams MC, Brock JW, Tanaka ST. Incidence of abnormal imaging and recurrent pyelonephritis after first febrile urinary tract infection in children 2 to 24 months old. J Urol. 2013;190(4S):1505–10. https://doi.org/10.1016/j.juro.2013.01.049.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Valavi E, Ziaee Kajbaf T, Ahmadzadeh A, Nikfar R, Najafi R. Clinical correlation between findings of renal scintigraphy and clinical/laboratory findings in children with febrile UTI. Jundishapur Sci Med J. 2012;11(1):35–42.

    Google Scholar 

  21. Schwartz GJ, Munoz A, Schneider M, Mak R, Kaskel F, Warady B, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629–37. https://doi.org/10.1681/ASN.2008030287.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ayazi P, Mahyar A, Daneshi MM, Hashemi HJ, Pirouzi M, Esmailzadehha N. Diagnostic accuracy of the quantitative C-reactive protein, erythrocyte sedimentation rate and white blood cell count in urinary tract infections among infants and children. Malays J Med Sci. 2013;20(5):40–6 PMID: 24643248.

    PubMed  PubMed Central  Google Scholar 

  23. Kahbazi M, Sharafkhah M, Yousefichaijan P, Taherahmadi H, Rafiei M, Kaviani P, et al. Vitamin a supplementation is effective for improving the clinical symptoms of urinary tract infections and reducing renal scarring in girls with acute pyelonephritis: a randomized, double-blind placebo-controlled, clinical trial study. Complement Ther Med. 2019;42:429–37. https://doi.org/10.1016/j.ctim.2018.12.007.

    Article  PubMed  Google Scholar 

  24. Farrell D, Morrissey I, De Rubeis D, Robbins M, Felmingham DA. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Inf Secur. 2003;46(2):94–100. https://doi.org/10.1053/jinf.2002.1091.

    Article  CAS  Google Scholar 

  25. Mahmoudi H, Emadmomtaz H, Karimitabar Z, Emam AH, Alikhani MY. Prevalence of asymptomatic urinary tract infection in primary school children of Hamadan City and drug resistance of isolated microorganisms in 2014. Pajouhan Sci J. 2015;13(3):8–14 http://psj.umsha.ac.ir/article-1-144-en.html.

    Google Scholar 

  26. Sarvari G, Ghane Sharbaf F, Partovi S, Elmi S, Akhavan H, Bakhtiari E. The relationship between chronic constipation and urinary tract infection in children: A case-control clinical study. Int J Pediatr. 2017;5(9):5715–21. https://doi.org/10.22038/ijp.2017.23109.1938.

    Article  Google Scholar 

  27. Muhammad S, Nawaz G, Jamil I, Ur Rehman A, Hussain I, Akhter S. Constipation in pediatric patients with lower urinary tract symptoms. J Coll Physicians Surg Pak. 2015;25(11):815–8 https://doi.org/11.2015/jcpsp.815818.

    PubMed  Google Scholar 

  28. Yang S, Chua ME, Bauer S, Wright A, Brandstrom P, Hoebeke P, et al. Diagnosis and management of bladder bowel dysfunction in children with urinary tract infections: a position statement from the international Children’s continence society. Pediatr Nephrol. 2018;33:2207–19. https://doi.org/10.1007/s00467-017-3799-9.

    Article  PubMed  Google Scholar 

  29. Lorenzo AJ, Rickard M, Dos Santos J. The role of bladder function in the pathogenesis and treatment of urinary tract infections in toilet-trained children. Pediatr Nephrol. 2020;35:1395–408. https://doi.org/10.1007/s00467-019-4193-6.

    Article  PubMed  Google Scholar 

  30. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128(3):595–610. https://doi.org/10.1542/peds.2011-1330.

    Article  Google Scholar 

  31. Nickavar A, Sadeghi-Bojd S. Alteration of platelet indices in young children with acute pyelonephritis. Int J Pediatr. 2020;8(8):11743–9. https://doi.org/10.22038/ijp.2020.47464.3849.

    Article  Google Scholar 

  32. Shaikh N, Shope TR, Hoberman A, Vigliotti A, Kurs-Lasky M, Martin JM. Association between uropathogen and pyuria. Pediatrics. 2016;138(1):e20160087. https://doi.org/10.1542/peds.2016-0087.

    Article  PubMed  Google Scholar 

  33. Renata Y, Jassar H, Katz R, Hochberg A, Nir RR, Klein-Kremer A. Urinary concentration of cytokines in children with acute pyelonephritis. Eur J Pediatr. 2013;172(6):769–74. https://doi.org/10.1007/s00431-012-1914-2.

    Article  CAS  PubMed  Google Scholar 

  34. Levine AR, Tran M, Shepherd J, Naut E. Utility of initial procalcitonin values to predict urinary tract infection. Am J Emerg Med. 2018;36(11):1993–7. https://doi.org/10.1016/j.ajem.2018.03.001.

    Article  PubMed  Google Scholar 

  35. Yilmaz A, Sevketoglu E, Gedikbasi A, Karyagar S, Kiyak A, Mulazimoglu M, et al. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol. 2009;24:2387–92. https://doi.org/10.1007/s00467-009-1279-6.

    Article  PubMed  Google Scholar 

  36. Lee YJ, Lee JH, Park YS. Risk factors for renal scar formation in infants with first episode of acute pyelonephritis: a prospective clinical study. J Urol. 2012;187:1032–6. https://doi.org/10.1016/j.juro.2011.10.164.

  37. Shah G, Upadhyay J. Controversies in the diagnosis and management of urinary tract infections in children. Paediatr Drugs. 2005;7:339–46. https://doi.org/10.2165/00148581-200507060-00002.

  38. Lapić I, Padoan A, Bozzato D, Plebani M. Erythrocyte sedimentation rate and C-reactive protein in acute inflammation: meta-analysis of diagnostic accuracy studies. Am J Clin Pathol. 2020;153(1):14–29. https://doi.org/10.1093/AJCP/AQZ142.

    Article  PubMed  Google Scholar 

  39. Naseri M. Alterations of peripheral leukocyte count, erythrocyte sedimentation rate, and C-reactive protein in febrile urinary tract infection. Iran J Kidney Dis. 2008;2(3):137–42.

    PubMed  Google Scholar 

  40. Jung SJ, Lee JH. Prediction of cortical defect using C-reactive protein and urine sodium to potassium ratio in infants with febrile urinary tract infection. Yonsei Med J. 2016;57(1):103–10. https://doi.org/10.3349/ymj.2016.57.1.103.

    Article  CAS  PubMed  Google Scholar 

  41. Rodríguez LM, Robles B, Marugán JM, Suárez Á, Santos F. Urinary interleukin-6 is useful in distinguishing between upper and lower urinary tract infections. Pediatr Nephrol. 2008;23:429–33. https://doi.org/10.1093/ofid/ofv098.

    Article  CAS  PubMed  Google Scholar 

  42. Lin DS, Huang SH, Lin CC, Tung YC, Huang TT, Chiu NC, et al. Urinary tract infection in febrile infants younger than eight weeks of age. Pediatrics. 2000;105(2):E20. https://doi.org/10.1542/peds.105.2.e20.

    Article  CAS  PubMed  Google Scholar 

  43. Razek AA, El-Basyouni SR. Ultrasound of knee osteoarthritis: interobserver agreement and correlation with Western Ontario and McMaster universities osteoarthritis. Clin Rheumatol. 2016;35:997–1001. https://doi.org/10.1007/s10067-015-2990-2.

    Article  PubMed  Google Scholar 

  44. Christian MT, McColl JH, MacKenzie JR, Beattie TJ. Risk assessment of renal cortical scarring with urinary tract infection by clinical features and ultrasonography. Arch Dis Child. 2000;82(5):376–80. https://doi.org/10.1136/adc.82.5.376.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Ki SC. Ultrasonography of acute flank pain: a focus on renal stones and acute pyelonephritis. Seoul, Korea: Department of Radiology, Korea University Anam Hospital, Korea University College of Medicine; 2017.

    Google Scholar 

  46. Ramzan MM, Sandstrom CK. Core curriculum illustration: acute pyelonephritis. Emerg Radiol. 2017;24(5):595–7. https://doi.org/10.1007/s10140-016-1474-2.

    Article  PubMed  Google Scholar 

  47. Razek AA, Fouda NS, Elmetwaley N, Elbogdady E. Sonography of the knee joint. J Ultrasound. 2009;12:53–60. https://doi.org/10.1016/j.jus.2009.03.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Okeahialam NA, Taithongchai A, Sultan AH, Thakar R. Transperineal and endovaginal ultrasound for evaluating sub-urethral masses: a comparison to magnetic resonance imaging. Ultrasound Obstet Gynecol. 2020. https://doi.org/10.1002/uog.23123.

  49. Doğan ÇS, Koyun NS, Aksoy GK, Çekiç B, Savaş M, Çomak E. Delayed diagnosis of primary vesicoureteral reflux in children with recurrent urinary tract infections: diagnostic approach and renal outcomes. Turk J Urol. 2018;44(6):498–502. https://doi.org/10.5152/tud.2018.98372.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Shrestha S, Bhandary S, Dwa Y, Jaiswal P, Parmar B, Karki DB. Renal ultrasound and voiding cystourethrogram in children with recurrent urinary tract infection. J Patan Acad Health Sci. 2017;4(2):49–52. https://doi.org/10.3126/jpahs.v4i2.24586.

    Article  Google Scholar 

  51. Şahin Ö, Taşbent FE. Comparison of DMSA scintigraphy and USG in detecting renal cortical scars in children with urinary tract infection. J Pediatr Infect Dis. 2018;13(3):210–5. https://doi.org/10.1055/s-0038-1642595.

    Article  Google Scholar 

  52. Tullus K. What do the latest guidelines tell us about UTIs in children under 2 years of age. Pediatr Nephrol. 2012;27:509–11. https://doi.org/10.1007/s00467-011-2077-5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the hospital staff and patients’ parents who assisted with this research.

Funding

The authors did not receive any financial support for conducting this research or preparing this manuscript.

Author information

Authors and Affiliations

  1. Children’s Hospital Medical Centre, Tehran University of Medical Sciences, Tehran, Iran

    Daryoosh Fahimi

  2. Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

    Leila Khedmat

  3. Department of Pediatric Nephrology, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran

    Azadeh Afshin, Zahra Noparast & Sayed Yousef Mojtahedi

  4. Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Maryam Jafaripor

  5. Department of Pediatric Intensive Care Unit, Bahrami Children’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

    Effat Hosseinali Beigi & Maryam Ghodsi

  6. Department of Pediatric Infection Disease, Tehran University of Medical Sciences, Tehran, Iran

    Anahita Izadi

Authors
  1. Daryoosh Fahimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leila Khedmat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Azadeh Afshin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zahra Noparast
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maryam Jafaripor
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Effat Hosseinali Beigi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maryam Ghodsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Anahita Izadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sayed Yousef Mojtahedi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MJ and EHB performed research and analyzed data; SYM, AI, and DF designed research, interpreted the data, and critically reviewed the manuscript; LK, AA, MG, and ZN drafted the work and substantively contributed to scientific editions and discussions. All authors approved the final version of the manuscript to be published.

Corresponding author

Correspondence to Sayed Yousef Mojtahedi.

Ethics declarations

Ethics approval and consent to participate

The performed study’s protocol was following the principles of the declaration of Helsinki and the Nuremberg Code and approved by the Ethics Committee of Tehran University of Medical Sciences. The project approval number is IR.TUMS.MEDICINE.REC.1396.3662. An oral and written informed consent was obtained from the parents/guardians of the minors included in this study.

Consent for publication

Not applicable.

Competing interests

The authors have declared no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fahimi, D., Khedmat, L., Afshin, A. et al. Clinical manifestations, laboratory markers, and renal ultrasonographic examinations in 1-month to 12-year-old Iranian children with pyelonephritis: a six-year cross-sectional retrospective study. BMC Infect Dis 21, 189 (2021). https://doi.org/10.1186/s12879-021-05887-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-021-05887-1

Keywords

BMC Infectious Diseases

ISSN: 1471-2334

Contact us